Standard Life Investments LTD raised its position in shares of Equifax Inc. (NYSE:EFX) by 23.6% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,032,294 shares of the company’s stock after buying an additional 196,930 shares during the period. Standard Life Investments LTD’s holdings in Equifax were worth $132,532,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. American Century Companies Inc. acquired a new stake in Equifax during the second quarter worth $90,891,000. Credit Agricole S A boosted its stake in Equifax by 485.3% in the first quarter. Credit Agricole S A now owns 420,030 shares of the company’s stock worth $48,005,000 after buying an additional 348,262 shares in the last quarter. Samlyn Capital LLC acquired a new stake in Equifax during the first quarter worth $33,099,000. AMF Pensionsforsakring AB boosted its stake in Equifax by 86.9% in the first quarter. AMF Pensionsforsakring AB now owns 377,743 shares of the company’s stock worth $43,172,000 after buying an additional 175,682 shares in the last quarter. Finally, Nuveen Asset Management LLC boosted its stake in Equifax by 1,121.0% in the first quarter. Nuveen Asset Management LLC now owns 174,364 shares of the company’s stock worth $19,928,000 after buying an additional 160,083 shares in the last quarter. 88.64% of the stock is owned by hedge funds and other institutional investors.
Equifax Inc. (NYSE:EFX) traded down 0.52% on Tuesday, reaching $133.27. The company’s stock had a trading volume of 402,075 shares. The company has a market cap of $15.90 billion, a P/E ratio of 34.70 and a beta of 0.87. The stock’s 50 day moving average price is $132.45 and its 200 day moving average price is $125.97. Equifax Inc. has a 12 month low of $91.72 and a 12 month high of $136.97.
Equifax (NYSE:EFX) last released its earnings results on Wednesday, July 27th. The company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. Equifax had a return on equity of 24.51% and a net margin of 16.11%. The firm earned $811.30 million during the quarter, compared to analysts’ expectations of $802.85 million. During the same period in the prior year, the company earned $1.15 earnings per share. The company’s quarterly revenue was up 19.6% on a year-over-year basis. Equities research analysts forecast that Equifax Inc. will post ($0.47) earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 15th. Shareholders of record on Friday, August 19th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend was Wednesday, August 17th. Equifax’s payout ratio is presently 34.38%.
EFX has been the subject of several research reports. Zacks Investment Research raised Equifax from a “hold” rating to a “buy” rating and set a $147.00 target price for the company in a research note on Tuesday, September 27th. Deutsche Bank AG lifted their target price on Equifax from $125.00 to $145.00 and gave the company a “buy” rating in a research note on Friday, July 29th. Jefferies Group reissued a “hold” rating and issued a $128.00 target price on shares of Equifax in a research note on Thursday, July 28th. Barclays PLC lifted their target price on Equifax from $140.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, September 21st. Finally, Stifel Nicolaus lifted their target price on Equifax from $131.00 to $143.00 and gave the company a “buy” rating in a research note on Friday, July 29th. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Equifax has a consensus rating of “Buy” and a consensus price target of $140.11.
In other news, Chairman Richard F. Smith sold 120,000 shares of the stock in a transaction on Friday, August 12th. The stock was sold at an average price of $132.63, for a total value of $15,915,600.00. Following the completion of the transaction, the chairman now directly owns 264,796 shares in the company, valued at approximately $35,119,893.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Paulino R. Barros sold 5,205 shares of the stock in a transaction on Wednesday, August 31st. The shares were sold at an average price of $132.00, for a total value of $687,060.00. Following the completion of the transaction, the insider now owns 10,786 shares of the company’s stock, valued at $1,423,752. The disclosure for this sale can be found here. Company insiders own 2.01% of the company’s stock.
Equifax Company Profile
Equifax Inc is a provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Personal Solutions. USIS provides consumer and commercial information solutions to businesses in the United States, including online information, decisioning technology solutions, fraud and identity management services, portfolio management services, mortgage reporting and financial marketing services.
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX).
Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.